e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Genetics of airway diseases and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
EGFR
,
HER2
and
KRAS
mutational status according to adenocarcinoma patterns/sub-types
L. Carvalho, M. J. d‘Aguiar, L. Teixeira, P. Couceiro, A. Alarcão, V. Sousa, M. Silva (Coimbra, Portugal)
Source:
Annual Congress 2011 - Genetics of airway diseases and treatment
Session:
Genetics of airway diseases and treatment
Session type:
Poster Discussion
Number:
446
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Carvalho, M. J. d‘Aguiar, L. Teixeira, P. Couceiro, A. Alarcão, V. Sousa, M. Silva (Coimbra, Portugal).
EGFR
,
HER2
and
KRAS
mutational status according to adenocarcinoma patterns/sub-types. Eur Respir J 2011; 38: Suppl. 55, 446
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Curette lavage fluid analysis of
EGFR
,
KRAS
, and
P53
mutations in lung cancer patients
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
Multiple kinds of cancer in one person – Lung and breast cancer – And other malignant entities
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler®
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Detection of lung cancer on CXR – A comparison of radiologist‘s performance
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
The mutation characteristics of the
bla
CTX-M/SHV/TEM
–producing
Klebsiella pneumoniae
clinical isolates in multicenter in China
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Alterations in
ORMDL
expression in experimental esthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012
Is the speed & likelihood of diagnosis of lung cancer influenced by referral origin?
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
"Loss of function" variants of the
P2RX7
gene in Czech patients with sarcoidosis: A genetic association study
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
Inhibitor of DNA-binding (Id) – 1 and 3 proteins overexpression has impact on prognosis of lung adenocarcinoma
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
6-minute-walk in lung cancer – a new predictor for response and the performance status?
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Accuracy of
EGFR
and
K-Ras
mutation detection in non small cell lung carcinoma: Ring trial in 15 molecular French laboratories (ERMETIC project – Part 1)
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010
T spot TB reactivity – ²to treat or not to treat²
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Tuberculoma of the lung – a report of 61 cases
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009
Patients‘ and family members‘ worries and concerns regarding ‘swine flu‘: A mixed methods study
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept